The Ronald M. Loeb Center for Alzheimer's Disease

Through the generous support of donors, our researchers at The Ronald M. Loeb Center for Alzheimer's Disease continue to make significant strides in understanding Alzheimer's disease mechanisms, developing early detection methods, and creating potential treatment pathways.

Your contribution directly enables our multidisciplinary teams to pursue innovative approaches in genetics, cellular neurobiology, biomarker development, and clinical trials. By supporting the Center, you become a partner in translating scientific discoveries into better outcomes for patients and families affected by Alzheimer's disease.

About Our Founding Donors

Daniel Loeb and Margaret Munzer Loeb established The Ronald M. Loeb Center for Alzheimer's Disease in honor of Dan's father, who died in 2012 after an eight-year battle with the disease. The Loebs collaborated with Kenneth L. Davis, MD, the then CEO and President of the Mount Sinai Health System, to create a center with a multidisciplinary approach that brings together some of the best minds in Alzheimer's research, stem cell research, and genomics.

Daniel S. Loeb is CEO of Third Point LLC, a New York-based asset management firm founded in 1995. His philanthropic activities are driven by principles of individual human rights, including fighting against inequality and discrimination and for policies that lead to greater economic opportunity for all. A trustee of the Mount Sinai Health System, he has also been an advocate for education reform, criminal justice reform, and advancing freedom for LGBTQ individuals.

Daniel graduated from Columbia University with an A.B. in economics in 1983, endowed the Daniel S. Loeb Scholarship for undergraduate study there, and received the school's John Jay Award for distinguished professional achievement. In October 2020, he was awarded the Alexander Hamilton Award for his philanthropic service by the Manhattan Institute. Daniel and Margaret live in New York City with their three children.